Astellas Pharma Inc. (ALPMF) News Nov 7, 2014, 12:00

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Astellas Pharma Inc. (ALPMF) News Nov 7, 2014, 12:00 a.m.
MarketWatch News on ALPMF
Japan stocks drop, as China shares extend gains 2:30 a.m. April 6, 2012 - V. Phani Kumar
Japan shares edge lower as yen strengthens 7:36 p.m. Oct. 25, 2010 - Myra P. Saefong
Japan shares range-bound in early trade, pre-data 7:38 p.m. June 27, 2010 - Myra P. Saefong
Japanese shares end the morning session higher 10:04 p.m. June 23, 2010 - Myra P. Saefong
Japan shares fall; pharmaceuticals among decliners 7:36 p.m. May 16, 2010 - Myra P. Saefong
Japan shares climb as chip maker shares advance 7:35 p.m. May 12, 2010 - Myra P. Saefong
Japan budget highlights fiscal quandary 12:01 a.m. March 3, 2010 - Lisa Twaronite
Japanese drug makers put up a fight 10:29 p.m. March 2, 2010 - Myra P. Saefong
Japan shares near flat as drug makers weaken 7:35 p.m. March 2, 2010 - Myra P. Saefong
Japan shares up; chip makers gain amid Nasdaq rise 7:28 p.m. March 1, 2010 - Myra P. Saefong
Updates, advisories and surprises 7:31 p.m. Aug. 3, 2009 - MarketWatch
Astellas Pharma profit, sales slip on stronger yen 1:38 a.m. Aug. 3, 2009 - Lisa Twaronite
Astellas Pharma April-June net profit 44.0 bln yen 1:17 a.m. Aug. 3, 2009 - Lisa Twaronite
FDA panel urges clearance for Cardiome-Astellas heart drug 3:55 a.m. Dec. 12, 2007 - Robert Daniel
Stocks in focus for Thursday 6:00 p.m. May 30, 2007 - MarketWatch
Theravance: EMEA validates telavancin application 4:01 p.m. May 30, 2007 - Gabriel Madway
Stocks in focus for Tuesday 6:08 p.m. May 14, 2007 - MarketWatch
CV Therapeutics submits regadenoson application to FDA 3:38 p.m. May 14, 2007 - Gabriel Madway
Stocks in focus for Wednesday 7:41 p.m. Feb. 20, 2007 - MarketWatch
Theravance: FDA accepts NDA for telavancin 5:56 p.m. Feb. 20, 2007 - Gabriel Madway
Loading more headlines...
Advertisement
Other News on ALPMF
FibroGen on deck for IPO 1:46 p.m. Nov. 10, 2014 - Seeking Alpha
10-Q: MEDIVATION, INC. 4:54 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Astellas antifungal tagged an Orphan Drug 12:44 p.m. Nov. 3, 2014 - Seeking Alpha
Astellas Pharma's (ALPMF) CEO Yoshihiko Hatanaka on Q2 2014 Results - Earnings Call Transcript 1:33 p.m. Oct. 31, 2014 - Seeking Alpha
CHMP supports Xtandi label expansion 9:14 a.m. Oct. 24, 2014 - Seeking Alpha
10-Q: MEDIVATION, INC. 3:34 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Astellas Pharma's (ALPMF) Q2 2014 Results - Earnings Call Transcript 12:07 p.m. Aug. 1, 2014 - Seeking Alpha
Medivation, Astellas look to widen use of Xtandi cancer drug 8:12 a.m. March 18, 2014 - Seeking Alpha
Aveo, Astellas ending Tivozanib deal, colon-cancer work halted 7:29 a.m. Feb. 14, 2014 - Seeking Alpha
Ram Selvaraju: A Pair Of Companies Ride The Sea Change In Cancer Therapeutics 2:22 p.m. Feb. 7, 2014 - Seeking Alpha
Aveo ends trial of cancer drug due to low enrollment 7:46 a.m. Jan. 30, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 11:09 a.m. Jan. 25, 2014 - Seeking Alpha
Aveo says lead drug unlikely to succeed in colon cancer study, -15% 11:06 a.m. Dec. 13, 2013 - Seeking Alpha
10-Q: MEDIVATION, INC. 4:33 p.m. Nov. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
The New Doctor in the House: Consolidation 5:01 a.m. Feb. 3, 2011 - SmartMoney
Astellas's Strong Treatment For OSI 3:49 p.m. March 1, 2010 - The Wall Street Journal Interactive Edition
Press Releases on ALPMF
Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global Service Initiative 1:22 a.m. Nov. 4, 2014 - PR Newswire - PRF
In 2023, Medivation/Astellas Pharma's Xtandi Will Be the Top-Selling Agent in the Prostate Cancer Market Across the United States, Europe, and Japan 12:00 p.m. Oct. 30, 2014 - PR Newswire - PRF
Vical Reports Third Quarter 2014 Financial Results and Progress in Key Development Programs 5:31 a.m. Oct. 30, 2014 - GlobeNewswire
QIAGEN Announces Broad Agreement With Astellas Pharma to Develop Companion Diagnostics 3:00 p.m. Oct. 28, 2014 - PR Newswire - PRF
Basilea reports protocol amendment resulting in earlier completion of isavuconazole phase 3 invasive candidiasis study 12:20 a.m. Oct. 16, 2014 - GlobeNewswire
Basilea reports protocol amendment resulting in earlier completion of isavuconazole phase 3 invasive candidiasis study 12:16 a.m. Oct. 16, 2014 - Thomson Reuters ONE
Astellas Teams Up with USA Rugby and Men's Health Network to Encourage Chicagoans to Answer the Challenge for Better Health 9:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Astellas Announces Research Collaboration With Harvard Medical School Investigator For Treatment Of Retinal Degeneration 7:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Cytokinetics Announces Development Program Update for CK-2127107 6:31 a.m. Oct. 13, 2014 - Thomson Reuters ONE
Brian McLellan Promoted to President of Astellas Pharma Technologies 4:31 p.m. Oct. 1, 2014 - PR Newswire - PRF
U.S. FDA Approves New Indication for the Use of XTANDI® (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer 3:39 p.m. Sept. 10, 2014 - PR Newswire - PRF
Cancer Research UK and Cancer Research Technology Join Forces with Astellas on Autophagy to Find New Cancer Treatments 8:00 a.m. Aug. 8, 2014 - PR Newswire - PRF
Vical Reports Second Quarter 2014 Financial Results and Progress in Key Development Programs 5:02 a.m. July 31, 2014 - GlobeNewswire
Global Parkinson%s Disease Market 2014-2018 5:42 p.m. July 28, 2014 - PR Newswire - PRF
Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry 3:27 p.m. July 15, 2014 - PR Newswire - PRF
Donna Ambrosino Joins ClearPath Vaccines Company as Chief Medical Officer 8:00 a.m. July 15, 2014 - PR Newswire - PRF
Veloxis Announces Positive Two-Year Results from Pivotal Phase 3 Study of Envarsus® XR (tacrolimus extended-release tablets) in de novo Kidney Transplant Patients 10:50 a.m. June 23, 2014 - PR Newswire - PRF
Astellas Pharma Returns to 'Give Kids The World' and Expands Partnership with Starlight Children's Foundation to Brighten the Lives of Young Patients & Their Families 8:00 a.m. June 11, 2014 - PR Newswire - PRF
Nidec Corp. Retains Top Spot on Institutional Investor's All-Japan Executive Team 1:45 a.m. June 5, 2014 - Marketwire
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial of Enzalutamide in Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy 8:02 a.m. June 1, 2014 - Marketwire
Loading more headlines...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FL Technics Indonesia Expands with EASA Certification

Updated Category News Views 100

Bali's Skies Just Got a Major Upgrade Picture this: You've got a sprawling 17,000 square meter facility sitting pretty at I Gusti Ngurah Rai International Airport, nestled in the paradise locale of Bali. What's next? It's now flexing some serious muscles with its newfound EASA Part-145 certification, allowing it to tackle aircraft registered in the European Union. This is...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 132

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
111, Inc. Strategizes with Advisors Amid Proposal Talks

Updated Category News Views 105

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

Continue Reading
Redwood and SAP Partner on Secure File Transfer

Updated Category News Views 199

Redwood Advances SAP Interiors with New File Solution October 26, '26 is now a landmark for Redwood Software. They've just rolled out their SAP Managed File Transfer solution. Got the brainpower behind Redwood and SAP operating together here, and they're offering this to enterprises aimed at optimizing their file-based workflow. If you're scratching your head just hearing...

Continue Reading
Electra's Ultra Short Aircraft Revolutionizes Air Travel

Updated Category News Views 53

From Tarmacs to Heliports: A New Era in Air Travel The aviation world doesn’t often see a sea change, but when a fixed-wing flyer touches down at a heliport, it grabs your attention. Electra’s recent leap into Manhattan’s Downtown Skyport highlights a promising shift in regional air mobility, doing away with the age-old reliance on long runways. It’s a shift that...

Continue Reading
United Vein Expands Vero Beach Network for Specialized Care

Updated Category News Views 0

Simplifying Vein Healthcare in Vero Beach Out of all the surprises life throws, leg cramps and bulging veins seem like small potatoes—until they're not. That's why folks in Vero Beach got a new lifeline today with the United Vein & Vascular Centers opening another clinic. At the crossroads of the 37th Street medical district, this place puts specialized vein care right...

Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom

Updated Category News Views 29

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Continue Reading
Natural Field Reinvents Supplement Delivery at SupplySide

Updated Category News Views 11

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Continue Reading
Elbit Systems Lands $200M APAC ISTAR Contracts

Updated Category News Views 74

Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...

Continue Reading
Boar's Head Introduces Authentic Italian Ricotta

Updated Category News Views 0

Boar's Head Brings Verona's Ricotta Stateside Imagine walking into your kitchen and finding a slice of authentic Italy sitting right there on your counter. That's what Boar's Head promises with its introduction of Italian Ricotta All Natural Cheese. It’s not just cheese; it’s a culinary passport straight from Verona, Italy, crafted using traditional techniques that...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Filed Against Lineage, Inc. by Robbins LLP

Updated Category News Views 238

Class Action Lawsuit Regarding Lineage, Inc. Robbins LLP has announced a class action lawsuit on behalf of investors who purchased common stock of Lineage, Inc. (LINE) in relation to its 2024 initial public offering. The firm aims to address concerns regarding the integrity of the company’s registration statement. The Allegations Against Lineage, Inc. The core of the...

Continue Reading
Perplexity AI Aiming for Record $8 Billion Valuation Growth

Updated Category News Views 262

Perplexity AI's Ambitious Valuation Plans Perplexity AI, a company backed by Jeff Bezos, is currently in discussions to secure funding that could significantly enhance its valuation. Recent reports indicate that the firm aims to more than double its current valuation to an impressive $8 billion or higher. This exciting development highlights the growing interest in...

Continue Reading
Atossa Therapeutics Spotlights Innovations in Breast Cancer Care

Updated Category News Views 37

Atossa Therapeutics Highlights Breast Cancer Awareness Month Atossa Therapeutics, Inc. (NASDAQ: ATOS), a pioneering biopharmaceutical company in breast cancer therapeutics, is celebrating Breast Cancer Awareness Month this October. This month serves as a critical reminder of the necessity for heightened awareness, research advancement, and the development of...

Continue Reading
Key Stocks to Monitor This Week: ABM and Broadcom Insights

Updated Category News Views 164

Market Movements Overview As we move through Friday, U.S. stock futures are displaying a mix of volatility, creating a unique opportunity for investors. Let’s take a closer look at several key stocks that are worth monitoring as trading unfolds. ABM Industries Earnings Outlook Analysts are predicting that ABM Industries Incorporated (NYSE: ABM) will announce its...

Continue Reading
Apogee Therapeutics Reveals Pipeline Developments and Progress

Updated Category News Views 540

Significant Advancements in Apogee Therapeutics' Pipeline Apogee Therapeutics, Inc. (NASDAQ: APGE), a clinical-stage biotechnology firm, is excited to outline its recent progress and financial results for the previous fiscal year. Their ongoing commitment to developing innovative biologics aims to address major challenges in inflammatory and immunology markets. Exciting...

Continue Reading